Brimonidine is used in the treatment of ocular hypertension and glaucoma.

Brimonidine decreases the pressure in the eyeball by decreasing the formation of aqueous humor (clear watery fluid filling the space in front of an eyeball ).

Headache, Foreign body sensation in eyes, Blurred vision, Dryness in mouth, Burning sensation in eye, Conjunctival hyperemia , Fatigue, Stinging in the eyes, Drowsiness, Eye itching, Allergic reaction in eye

• Helps lower high pressure in the eye and reduces the risk of vision loss.
• For best results, put one drop 2-3 times daily in the affected eye(s).
• Brimonidine may cause allergic reaction in the form of eyelid swelling, eye discomfort, foreign-object sensation, redness and itching. Notify your doctor if any of these occur.
• Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop. This minimizes the risk of side effects.
• Take care to prevent contact of eye dispenser with eye, eyelid, eyelashes, or finger to avoid infection.
• Remove contact lenses before using Betagan and allow at least 15 minutes before re-inserting them.
• When applying multiple eye medications, wait for at least 5-15 minutes before delivering the next medication in the same eye to avoid dilution.

Ques. Q. Is Brimonidine the same as Alphagan?
Yes, Alphagan is a trade name of drug Brimonidine

Ques. Q. Is Brimonidine or Brimonidine tartrate a beta blocker/steroid?
Brimonidine or Brimonidine tartrate is a sympatomimetic drug and not a beta blocker/steroid

Ques. Q. Does Brimonidine cause fatigue?
Yes, feeling fatigue is a very common side effect of Brimonidine. Always consult your doctor if you experience such type of side effect

Ques. Q. Why does Brimonidine cause miosis?
Brimonidine causing this side effect is very rare. It may be because of overdose of other alpha2-agonists. Always consult your doctor if you experience such type of side effect

Ques. Q. How does Brimonidine lower intraocular pressure (iop)?
It reduces the intraocular pressure by reducing the amount of fluid in the eye.